Avantor Results Presentation Deck

Q2 core organic revenue growth Core organic revenue growth 6.4% Navantor™ CORE ORGANIC REVENUE GROWTH BY END MARKET SERVED % of total sales: Biopharma 53% % of total sales: +HSD CORE ORGANIC REVENUE GROWTH BY PRODUCT Proprietary materials and consumables 39% +DD Healthcare 9% -LSD Note: LSD 1-3% / MSD 4-6% / HSD 7-9% / DD >10%. Education and government 12% -LSD Third-party materials and consumables 36% +MSD Services and specialty procurement 13% +LSD Advanced technologies and applied materials 26% +DD Equipment and instrumentation 12% +MSD 8

View entire presentation